THC is the most widely recognized cannabinoid found in cannabis and is primarily associated with intoxicating effects. It interacts mainly with CB1 receptors in the brain and central nervous system, influencing perception, mood, and sensory experience.

The effects of THC can differ based on factors such as dosage, individual tolerance, and method of consumption. Commonly reported experiences may include relaxation, altered sensory awareness, increased appetite, or drowsiness. Because THC is fat-soluble, it can be stored in the body’s fat cells for extended periods.

THC is also the primary cannabinoid responsible for the traditional “high” associated with cannabis and is commonly discussed in both adult-use and regulated medical contexts.

CBD is a non-intoxicating cannabinoid found in both cannabis and hemp plants. Unlike THC, CBD does not produce euphoric effects and interacts differently with the body’s systems.

CBD has gained attention for its potential role in supporting balance and relaxation. Ongoing research continues to explore how CBD interacts with various receptors and systems within the body. In regulated medical settings, CBD-based formulations have been approved for specific, limited uses.

Because it does not produce intoxication, CBD is often explored by individuals seeking cannabis options without psychoactive effects.

CBN is a minor cannabinoid that forms as THC naturally degrades over time, particularly when exposed to light and air. It is typically found in small amounts in aged cannabis.

CBN is often associated with calming or relaxing effects and may exhibit very mild psychoactivity compared to THC. Research into CBN is ongoing, and interest continues to grow around its potential role in relaxation-focused products.

CBG is a non-intoxicating cannabinoid known as a precursor compound, meaning it plays a role in the development of other cannabinoids such as THC and CBD.

It appears early in the cannabis plant’s growth cycle and is usually present in lower concentrations once the plant matures. Researchers are actively studying CBG to better understand how it interacts with the endocannabinoid system and how it may work alongside other cannabinoids and terpenes.

CBC is a lesser-known cannabinoid that is typically found in younger cannabis plants. It does not produce intoxicating effects and interacts with the body differently than THC.

Early research suggests CBC may play a role in supporting the body’s natural processes related to balance and inflammation. Continued study is needed to fully understand its potential applications and interactions.

THCv is structurally similar to THC but behaves differently within the body. Depending on the amount consumed, it may interact with cannabinoid receptors in unique ways.

At lower levels, THCv may influence appetite and energy differently than THC, while higher amounts may affect how THC interacts with the body. Research into THCv is still developing, with ongoing studies exploring its distinct properties.

CBGA is often referred to as the “parent” cannabinoid, as it serves as the starting point for the formation of many other cannabinoids. As the cannabis plant matures, enzymes convert CBGA into compounds such as THCa, CBDA, and CBCA.

CBGA itself is non-intoxicating and exists in raw cannabis. Researchers continue to study its role in the plant and its potential significance in cannabinoid development and strain cultivation.

THCa is the raw, acidic form of THC found in unheated cannabis plants. It does not produce intoxicating effects in its natural state.

When heat is applied through smoking, vaporizing, or cooking, THCa converts into THC through a process called decarboxylation. Interest in THCa has increased as research continues into its properties and how it differs from its activated form.